Impact of a Clinical Pathway for Pelvic Fragility Fractures
Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Sep 19, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment plan for patients who have suffered pelvic fragility fractures, which are injuries that often occur from low-energy falls, especially in older adults. The goal is to create a standardized way to treat these injuries that can help improve recovery and reduce complications. Currently, there is no consistent treatment approach, leading to different practices across hospitals. This study aims to implement a clinical pathway based on the latest research and experience to provide better care for these patients.
To be eligible for the trial, participants must have a pelvic fracture caused by a low-energy fall and need to be treated at a participating hospital's emergency room or outpatient clinic. However, individuals who have certain severe health issues, like advanced cancer in the pelvic area, or those who cannot follow instructions due to cognitive problems, will not be included. Participants can expect to receive specialized care designed to help them recover more effectively, and the study is currently looking for people aged 18 and older to join. If you or a loved one has experienced this type of injury, this trial might offer an opportunity for improved treatment and support during recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pelvic fragility fracture caused by low energetic trauma
- • Patients presented at the emergency room or out-patient clinic of a participating hospital
- Exclusion Criteria:
- • Patients with high suspicion of a pelvic fracture due to a malignant tumor
- • Patients who are unable to follow instructions due to severe cognitive decline (for example due to dementia or Alzheimer's disease)
- • Patients who pre-trauma received palliative or terminal care
- • Patients who pre-trauma were wheelchair bound or bedridden
- • Patients who suffer from complications from previous pelvic ring fixation
- • Patients with insufficient comprehension of the Dutch language to be able to carry out the physiotherapy instructions for early mobilization
About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)
The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zaandam, Noord Holland, Netherlands
Haarlem, Noord Holland, Netherlands
Amsterdam, Noord Holland, Netherlands
Hoorn, Noord Holland, Netherlands
Amsterdam, Noord Holland, Netherlands
Almere, Flevoland, Netherlands
Alkmaar, Noord Holland, Netherlands
Amsterdam, Noord Holland, Netherlands
Patients applied
Trial Officials
Frank W Bloemers, prof
Principal Investigator
Amsterdam UMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported